Daiken Biomedical Co (7780.TWO) Stock Price
Daiken Biomedical Co Price
Revenue has compounded at 24.1% per year over the past 2 years to 1.36 B TWD. Earnings per share have grown at 8.7% per year over the last 2 years. Daiken Biomedical Co's net margin stands at 7.8%, down from 10.2% several years earlier. Daiken Biomedical Co currently offers a dividend yield of about 4.33%.
Daiken Biomedical Co stock price
Daiken Biomedical Co business model & stock analysis
Frequently asked questions about Daiken Biomedical Co
7 analysts currently rate the Daiken Biomedical Co stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Daiken Biomedical Co to generate revenue of 3.05 B TWD and earnings per share of 9.83 TWD.
Converted at the current exchange rate, the Daiken Biomedical Co share trades at 0.46 EUR (16.55 TWD).
The expected revenue of Daiken Biomedical Co is 3.05 B TWD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Daiken Biomedical Co is 589.86 M TWD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Daiken Biomedical Co is currently 1.68. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Daiken Biomedical Co stock.
The price-to-sales ratio (P/S) of Daiken Biomedical Co is currently 0.33. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Daiken Biomedical Co stock.
The Eulerpool Quality Score for Daiken Biomedical Co is 3/10.
The ISIN of Daiken Biomedical Co is TW0007780009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Daiken Biomedical Co is 7780.TWO. The ticker symbol is used to trade Daiken Biomedical Co shares on the stock exchange.
Daiken Biomedical Co stock
Daiken Biomedical Co Peer Group
All fundamentals and in-depth analysis of Daiken Biomedical Co
Our stock analysis for Daiken Biomedical Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Daiken Biomedical Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.